n-Lorem Foundation Begins 2023 with More Than 80 Active Patient Programs
n-Lorem has industrialized the [...]
n-Lorem Foundation Welcomes New Members, Paul Compton and Neil Shneider, to its Board of Directors
Newest members bolster scientific [...]
n-Lorem Foundation Launches New Website to Support its Nano-rare Patients, Treating Physicians and Institutions
New website features patient, [...]
n-Lorem Foundation Initiates Clinical Trials for Three Nano-rare Patients
n-Lorem’s nano-rare patients include [...]
Sustainable Funding From a Diverse Donor Base Supports n-Lorem Foundation and its Nano-rare Patients
n-Lorem Foundation has exceeded [...]
n-Lorem Foundation Promotes Sarah Glass, Ph.D. to Chief Operating Officer
Dr. Glass’ strategic oversight and [...]
n-Lorem Foundation CEO, Stanley Crooke, M.D., Ph.D., Chosen as 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity of the Prix Galien
Prestigious award recognizes Dr. [...]
SOLVE FSHD Provides Funding to n-Lorem for a Collaboration to Expand Understanding of FSHD2, a Rare Form of Muscular Dystrophy
SOLVE FSHD contributes more than [...]
n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research
Invited Perspective Article [...]
n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients
Ultragenyx’s continued support bolsters n-Lorem’s [...]
